Remix Therapeutics

Remix Therapeutics is a clinical-stage biotechnology company dedicated to transforming patient lives through the modulation of RNA processing. Their innovative approach focuses on discovering and developing small molecule therapies that can control gene and protein expression by influencing how RNA is processed. Their proprietary drug discovery platform, REMaster™, has enabled them to identify novel, druggable target sites and active chemical matter, paving the way for potential new medicines.

Remix is currently advancing a broad pipeline of RNA processing modulators across Oncology and Neurodegeneration. Their lead candidate, REM-422, is a first-in-class MYB mRNA degrader currently being evaluated in Phase 1 clinical trials for the treatment of adenoid cystic carcinoma (ACC) and acute myeloid leukemia/myelodysplastic syndromes (AML/MDS). Their research has also resulted in collaborations with pharmaceutical giants like Roche and Janssen, signifying the potential impact of their innovative technology on the future of drug development.

Remix Therapeutics is a clinical-stage biotechnology company dedicated to transforming patients' lives by developing novel small molecule therapies that modulate RNA processing. Their mission is to reprogram RNA, the messenger molecule that carries genetic information, to address the underlying drivers of disease, ultimately offering new therapeutic options for patients with high unmet medical needs.

Remix Therapeutics cultivates a scientifically driven and collaborative culture, emphasizing a commitment to innovation and patient-centricity. They prioritize scientific integrity and mutual support between teammates, fostering an environment where diverse perspectives and creative problem-solving are valued. This collaborative culture is built on a foundation of courageous curiosity and a shared passion for delivering meaningful treatments to patients.

Remix Therapeutics values diversity and fosters an inclusive culture where individuals from a variety of backgrounds can contribute their unique perspectives and talents. They believe that a diverse workforce leads to innovative solutions and a stronger company. Remix is committed to creating an equitable environment for all employees, promoting fair treatment and opportunities for growth and development regardless of race, ethnicity, gender, sexual orientation, age, or disability.